Daniel S. Duffy Appointed New CEO of Camargo Pharmaceutical Services, LLC

Stocks and Financial Services Press Releases Wednesday May 2, 2018 08:05
CINCINNATI--2 May--PRNewswire/InfoQuest

Camargo Pharmaceutical Services, LLC, ("Camargo") the global leader in 505(b)(2) drug development and global equivalents, today announced the appointment of Daniel S. Duffy as new Chief Executive Officer. Kenneth V. Phelps, Founder and President, will continue to be the visionary ambassador for the company, building the industry and driving new opportunities for Camargo.

Camargo has been instrumental in helping global pharmaceutical companies identify, develop, and obtain numerous 505(b)(2) NDA approvals. Drugs developed through this pathway have benefited countless lives in the U.S. People worldwide benefit from drugs that have been improved.

"It has been an honor to lead this organization for 15 years and I am looking forward to expanding Camargo's impact globally. I am happy Dan is joining us to expand the organization to support this vision," said Phelps.

Dan brings over 20 years of experience in biopharma and strategic management consulting. Dan was most recently the Vice President and General Manager at McKesson Specialty Health. While there, he developed a differentiated specialty pharmacy model with Centers of Excellence around oncology, neurology and complex care, patient assistance and investigational product (clinical trials). Dan holds a Master of Business Administration from the University of North Carolina Kenan-Flagler School of Business and a Bachelor of Business Administration from Kent State University.

"I am grateful for the vote of confidence and the opportunity to be part of the Camargo family. Camargo is filled with exceptionally smart and capable people who are passionate about improving medicines that serve our community," said Duffy.

ABOUT CAMARGO PHARMACEUTICAL SERVICES, LLC.

Camargo Pharmaceutical Services, LLC, headquartered in Cincinnati, OH, was founded in 2003 by Kenneth V. Phelps (President and Founder) and Dr. Ruth Stevens (Chief Scientific Officer and Founder). Camargo provides comprehensive drug development services and specializes in the 505(b)(2) approval pathway and global equivalent processes. By assessing the scientific, medical, regulatory, and commercial viability of product development opportunities, Camargo builds and executes robust development plans that align with business strategies and ensures regulatory agency buy-in every step of the way. Routinely holding three to six meetings a month with the Food and Drug Administration (FDA), Camargo works with product developers across more than 25 countries. For more about Camargo, visit http://camargopharma.com .

Logo - https://mma.prnewswire.com/media/465303/Camargo_FullColor_Logo.jpg

Latest Press Release

mai welcomes real estate developer CMC on November 19

Market for Alternative Investment (mai) will list Chaoprayamahanakorn pcl, a leading real estate developer onNovember 19, under the ticker symbol "CMC". The company has a market capitalization at its initial public offering (IPO) of THB 3.00 billion...

KTC - Chilito Mexican Grill - Farm Factory provide members special privileges for payments made using QR Pay in the KTC Mobile app.

Mrs. Pranaya Nithananon, Vice President - Credit Card Business, "KTC" or Krungthai Card Public Company Limited, provides KTC VISA and KTC MasterCard credit card members who make payments through KTC QR Pay in the "KTC Mobile" app worth Bt. 300 or more...

Photo Release: KBank opens new flagship branch and THE WISDOM Lounge at ICONSIAM

Mr. Wirawat Panthawangkul (3rd from left), KBank Senior Executive Vice President, and Ms. Chadatip Chutrakul (4th from left), Director of ICONSIAM Co., Ltd., and Chief Executive Officer of Siam Piwat Co., Ltd., participated in the opening ceremony of...

Photo Release: CIMB Group Joins RippleNet to Power Instant Payments Across ASEAN

Tengku Dato' Sri Zafrul Aziz, Group CEO of CIMB Group (right), and Brad Garlinghouse, Ripple CEO (left) commemorating the strategic collaboration between CIMB Group and Ripple to power instant payments across ASEAN at the Singapore FinTech festival 2018...

CIMB Group Joins RippleNet to Power Instant Payments Across ASEAN

CIMB is one of the first banks to leverage blockchain technology to tap into region's USD120 billion remittance business CIMB Group ("CIMB" or "the Group") and Ripple have entered into a strategic collaboration to enable instant cross border payments...

Related Topics